Shacey Petrovic - 14 May 2021 Form 4 Insider Report for INSULET CORP (PODD)

Role: President and CEO, Director
Signature: /s/ John W. Kapples, attorney-in-fact
Issuer symbol: PODD
Transactions as of: 14 May 2021
Net transactions value: -$3,719,700
Form type: 4
Filing time: 02 Jul 2021, 16:08:43 UTC
Next filing: 02 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PODD	Common Stock	Gift	$0	-25,905	-62%	$0.000000	15,684	14 May 2021	Direct	F1
transaction	PODD	Common Stock	Gift	$0	+25,905		$0.000000	25,905	14 May 2021	By SP Trust	F1
transaction	PODD	Common Stock	Options Exercise	$458,700	+15,000	+95%	$30.58^*	30,779	01 Jul 2021	Direct	F2, F3
transaction	PODD	Common Stock	Sale	$4,178,400	-15,000	-49%	$278.56	15,779	01 Jul 2021	Direct	F2, F4
holding	PODD	Common Stock						87,495	14 May 2021	By NG Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PODD	Employee Stock Option (Right to Buy)	Options Exercise	$0	-15,000	-67%	$0.000000	7,436	01 Jul 2021	Common Stock	15,000	$30.58	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 14, 2021, the reporting person gifted 25,905 shares of Insulet common stock to a family trust of which the reporting person is the settlor and a trustee. The beneficiaries of the trust are members of the reporting person's immediate family.
F2	The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
F3	Includes 95 shares acquired under the Insulet Corporation Employee Stock Purchase Plan on May 28, 2021.
F4	The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $274.695 to $280.55. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F5	This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.